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Role of Human Umbilical Cord Mesenchymal Progenitors 
Conditioned Media in Neuronal/Glial Cell Densities, 
Viability, and Proliferation
Antonio J. Salgado,1,* Joana S. Fraga,1,* Ana R. Mesquita,1 Nuno M. Neves,2,3 
Rui L. Reis,2,3 and Nuno Sousa1
It has been recently reported that mesenchymal progenitor/stem cells isolated from the Wharton’s Jelly (WJ) of um-
bilical cords (UC) ameliorate the condition of animals suffering from central nervous system (CNS)-related condi-
tions. However, little is known on the mechanisms that regulate these actions. Therefore, the objective of the present 
work was to determine how the conditioned media (CM) of a population of mesenchymal progenitors present in 
the UC WJ, known as human umbilical cord perivascular cells (HUCPVCs), regulate processes such as cell viability, 
survival, and proliferation of postnatal hippocampal neurons and glial cells. For this purpose primary hippocampal 
and cortical cultures of neurons and glial cells, respectively, were incubated with CM from HUCPVCs. Results 
revealed that HUCPVCs CM increase glial cell viability and proliferation. Furthermore, it was observed that glial 
cell cultures exhibited higher numbers of GFAP-positive cells (astrocytes) and O4-positive cells (oligodendrocytes) 
when incubated with the CM. Additionally, it was also observed that the growth factors presents in the CM did not 
induce an increase on the microglial cells number. For hippocampal neurons similar results were obtained, as cul-
tures exposed to HUCPVCs CM disclosed higher numbers of MAP-2–positive cells. Moreover it was also observed 
that the cell viability and proliferation in this primary hippocampal cell culture system was also higher, when com-
pared to control cultures. From these results it was possible to conclude that HUCPVCs release neuroregulatory 
factors that have a direct impact on the densities, viability, and proliferation of glial cells and hippocampal primary 
cultures.
Introduction
Neurological disorders are typically chronic, debili-tating diseases that often lead to the premature death 
of af/ icted individuals, thereby imposing a harsh emo-
tional burden on their family members. These disorders, 
which include neurodegenerative diseases (Parkinson and 
Huntington disease), neuromuscular disorders, and met-
abolic genetic disorders, often pose unique challenges for 
treatment. This is mainly due to the low regenerative poten-
tial of the nervous tissue. In fact, unlike many other tissues, 
mature nerve cells lack the ability to regenerate, and neural 
stem cells, although present in the hippocampus and sub-
ventricular zone (SVZ) of the brain [1,2] have a limited abil-
ity to generate new functional neurons in response to injury 
[3]. Therefore there has been an increasing interest through-
out the years on the development of therapies that can 
 adequately promote neuro-regeneration. For instance, sev-
eral growth factors, with different degrees of success, have 
been explored for this purpose, including: nerve growth 
actor (NGF) [4], brain-derived neurotrophic factor (BDNF) 
[5], neurotrophin-3 (NT-3) [6], neurotrophin-4/5 (NT-4/5) 
[7], ciliary neurotrophic factor (CNTF) [8], 0 broblast growth 
factor 2 (FGF-2) [9], and erythropoietin (EPO) [10].
The transplantation/injection of stem/progenitor cells 
has also emerged as a possible strategy for the restoration 
of function following neuronal loss. Studies from different 
authors [11–15] have assessed the impact of mesenchymal 
stem/progenitor cells isolated from bone marrow or adipose 
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from the University of Toronto/Sunnybrook and Women’s 
College Health Sciences Centre, Toronto or the Hospital de S. 
Marcos, Braga, Portugal. HUCPVCs were isolated according 
to the procedure originally described by Sarugaser et al. [30]. 
Pieces of cord, 4–5 cm long, were dissected by 0 rst removing 
the epithelium of the UC section along its length to expose the 
underlying WJ. Each vessel, with its surrounding WJ matrix, 
was then pulled away, after which the ends of each dissected 
vessel were tied together with a suture creating “loops” 
that were placed into a 50-mL tube containing a solution 
of 0.5–0.75 mg/mL collagenase (Sigma, St. Louis, MO) with 
phosphate-buffered saline (PBS, Invitrogen/Gibco, Carlsbad, 
CA). After 18 h, the loops were removed from the suspension, 
which was then diluted with PBS to reduce the viscosity of the 
suspension and centrifuged. Following the removal of the su-
pernatant, cells were resuspended in culture media, α-MEM 
(Invitrogen/Gibco) supplemented with 10% FBS (Invitrogen/
Gibco) and 1% antibiotic/antimycotic (Sigma), counted using 
a hemocytometer and platted in T75 / asks at a density of 
4,000 cells/cm2. The culture medium was changed every 2/3 
days. Upon con/ uence cells were trypsinized and passaged 
to new T75 / asks.
Primary cultures of hippocampal neurons. Hippocampal 
neurons cultures were prepared from P4 Wistar Rats [32]. 
Brie/ y, and upon dissection, hippocampi were submitted to 
a trypsin-based enzymatic digestion followed by mechani-
cal dissociation. Isolated cells were then plated on coverslips 
previously coated with poly-d-lysine (Sigma) at a density of 
40,000 cells/cm2. Characterization of the cultures by immu-
nocytochemistry (microtubule-associated protein (MAP-2)-
 neurons; glial acidic 0 brillary protein (GFAP)-astrocytes; 
nestin-neuroprogenitors) revealed that they possessed 
 approximately 45%–50% of mature neurons, 5%–10% of astro-
cytes, and 35%–40% of neural progenitors, whenever grown in 
Neurobasal media supplemented with B27 (Invitrogen/Gibco) 
and FGF-2 (Invitrogen/Gibco). In the absence of these factors, 
there is a marked decrease in cell viability and the cultures 
remain essentially in an undifferentiated state. There is also a 
small contamination by other cell types, namely 0 broblasts and 
endothelial cells, which comprise <1% of the total culture.
Primary cultures cortical glial cells. Cortical glial cells were 
isolated from P4 newborn Wistar rats. Upon dissection, cor-
tices were enzymatically digested (30 mg/mL DNase, 0.25% 
Trypsin, both from Sigma) followed by a strong mechani-
cal dissociation. The mechanical dissociation allows a 
 better separation of the cells from the surrounding tissue. 
Simultaneously leads to cell death along neuronal cell popu-
lations, which are known to be quite more sensitive to these 
procedures. Glial cells were then obtained by centrifuging 
the resulting cell suspension at 800 rpm for 2 min, and plated 
out on coverslips previously coated with poly-d-lysine at 
a density of 40,000 cells/cm2. As for the hippocampal cul-
tures an immunocharacterization was performed, showing 
that the dominant cell type are microglial cells (45%–55%), 
followed by astrocytes (35%–45%) and oligodendrocytes 
(5%–10%). Similarly to what happened for neuronal cultures, 
there is a small contamination by other cell types, namely 
0 broblasts, which comprise <1% of the total culture.
Conditioned medium collection and experiments
Conditioned media (CM) were collected from P2 
HUCPVCs. For this purpose cells were plated out at a 
tissue on central nervous system (CNS)-related disorders. 
Interestingly, the administration of these cells was shown 
to promote neuronal survival and regeneration, stimulating 
also the proliferation and differentiation of resident cells, 
thus limiting the extent of neurological injury and impair-
ment in animal models of stroke [11,12], traumatic brain in-
jury [13,14], demyelination [15], and spinal cord injury [16,17].
More recently the Wharton Jelly (WJ) of the umbilical 
cord (UC), a gelatinous connective tissue consisting of myo-
0 broblast-like stromal cells, collagen 0 bers, and proteogly-
cans, was presented as source of stem/progenitor cells for 
CNS regeneration [18–21]. As shown by Karahuseyinoglu et 
al. [22] and reviewed by Troyer and Weiss [23], these cells are 
commonly isolated from 2 distinct areas of the UC namely 
the perivascular region and the intravascular area. When 
in culture they present a 0 broblast like morphology, being 
positive for the expression of mesenchymal stem cell (MSC) 
like markers such as CD10, CD13, CD44, CD90, CD117, and 
negative for hematopoietic markers. Additionally they also 
display a multipotential character, being able to differenti-
ate toward the osteogenic, chondrogenic, and adipogenic 
lineages [23]. Regarding possible applications of the latter 
to the CNS, Weiss and coworkers revealed that cells isolated 
from the bulk of the porcine WJ matrix, called umbilical 
cord matrix cells (UCMCs), could be observed in the brains 
of rats following transplantation without immunosuppres-
sive therapy [18]. Subsequent studies from the same authors 
have demonstrated that these cell populations could have an 
impact on the treatment of neurodegenerative diseases, such 
as Parkinson’s disease (PD) [19,20]. In fact, it was shown that 
injection of these cells in PD-induced animals triggered a 
behavioral improvement and increased the number of tyro-
sine hydroxylase (TH)-positive neurons [20]. Finally Hirko 
et al. [24] also demonstrated that UCSCs were able to modu-
late the in/ ammatory reaction within the brain, after global 
ischemia, disclosing a neuroprotector role within the CNS. 
However, little is known concerning the mechanisms under-
lying the interactions between the stem cell populations 
derived from the umbilical cord and the residing neuronal 
and glial cells. Although it has been reported that these cells 
differentiate toward the neuronal lineage [21,25], it is most 
likely that, similarly to what has been described to bone mar-
row mesenchymal stem cells [26–29], these effects are medi-
ated through the release of cytokines and growth factors.
Therefore, in the present study we determined how the 
conditioned media (CM) of human umbilical cord perivas-
cular cells (HUCPVCs), a population of cells with a known 
mesenchymal stem cell-like character [30,31], interact with 
primary cultures of post-natal hippocampal neurons and glial 
cells. As endpoints of these interactions, we assessed cell via-
bility, proliferation, and differentiation of CNS resident cells. 
Results revealed that HUCPVCs CM contained growth fac-
tors that increased astrocyte, oligodendrocyte, and neuronal 
metabolic viability, proliferation, and cell densities.
Materials and Methods
Cell culture
Human umbilical cord perivascular cells. HUCPVCs were ei-
ther a kind gift from Dr. J. E. Davies, University of Toronto, or 
isolated from the UCs from consenting full-term caesarean sec-
tion patients. Ethical approval had been previously obtained 
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Total protein quanti! cation
Total protein was quanti0 ed (n = 3/CM time point and 
control) through the bicinchoninic acid (BCA) Protein Assay 
kit (Pierce Chemical, USA), as previously demonstrated by 
Silva et al. [36]. This system uses BCA as the detection re-
agent for Cu1+, which is formed when Cu2+ is reduced by pro-
tein in an alkaline environment. The purple colored reaction 
product is formed by the chelation of 2 molecules of BCA 
with 1 cuprous ion (Cu1+). At the end of the assay, 100 μL of 
each sample were transferred to 96-well plates where a stan-
dard curve was prepared and the absorbance read at 562 nm 
in a multi-well plate reader (Tecan, Männedorf, Switzerland).
Immunocytochemistry
Cells were 0 xed in 4% paraformaldehyde for 30 min, per-
meabilized by incubation with 0.3% Triton X-100 in PBS for 5 
min at room temperature (for neurons and astrocytes), and 
washed 3 times in PBS. Cells were then blocked with 10% 
FBS/PBS (60 min), followed by a 60-min incubation with the 
primary antibodies: mouse anti-rat microtubule-associated 
protein 2 (MAP-2) (Sigma) to detect mature hippocampal 
neurons, rabbit anti-rat glial 0 brillary acid protein (GFAP) 
(Dako, Denmark) for astrocytes, mouse anti-CD11b (BD 
Biosciences Pharmigen, San Diego, CA) for microglial cells, 
and mouse anti-O4 (R&D systems, Minneapolis, MN) for 
oligodendrocytes. Cells were then washed in PBS and incu-
bated with Alexa Fluor 594 goat anti-mouse immunoglob-
ulin G (IgG; Invitrogen/Molecular Probes, Carlsbad, CA) or 
Alexa Fluor 488 rabbit anti-rat IgG (Invitrogen/Molecular 
Probes). Primary antibody was omitted to produce negative 
controls. Samples were observed under an Olympus BX-61 
Fluorescence Microscope (Olympus, Germany).
Cell counts
Cell counts were performed by using Cell-P software 
(Olympus, Germany). For this purpose 3 coverslips per con-
dition and 3 representative 0 elds were chosen and analyzed. 
In order to normalize the data between the different sets 
of cell culture, results are presented in number of cells/µg 
protein.
Statistical analysis
Statistical evaluation was performed using one-way 
ANOVA to assess the statistical differences between differ-
ent groups. Statistical signi0 cance was de0 ned as P < 0.05 
for a 95% con0 dence interval.
Results
In the present study we aimed at determining to what ex-
tent a population of mesenchymal progenitors derived from 
the umbilical cord, known as HUCPVCs, could in/ uence the 
in vitro densities, viability, and proliferation of post-natal 
hippocampal neurons and cortical glial cell populations.
In Figure 1, it is possible to observe that the incubation 
of glial cells with CM from HUCPVCs lead to an overall in-
crease of cell metabolic viability. All the values were above 
and signi0 cantly different (P < 0.05) when compared to 
control conditions. Moreover, it could also be observed that 
density of 4,000 cells/cm2 and allowed to grow for 3 days. 
Following this, culture medium was renewed and CM col-
lected 24, 48, and 72 h thereafter (cell culture media was not 
renewed or added during this time period). Upon collection 
CM were frozen, being later on thawed on the day of the 
experiments. For CM collection standard HUCPVCs culture 
medium was used for experiments with glial cells, while for 
experiments with hippocampal neurons, Neurobasal-A me-
dium supplemented was the chosen medium. Experiments 
with glial cells and hippocampal neurons were done as 
follows:
Hippocampal neurons. Upon isolation hippocampal neu-
rons were plated out at the densities referred above and in-
cubated from T0 with the previously collected CM (n = 3/
CM time point) for 7 days (with half of the volume of CM 
being renewed at day 4 of culture), after which cell densi-
ties, viability, and proliferation were assessed (see below). 
Besides kanamycin and glutamax, no further supplements 
were added to the HUCPVCs CM. Control cultures were 
kept in Neurobasal media supplemented with kanamycin 
and glutamax.
Glial cells. Upon isolation as referred in 2.1.3, glial cells 
were allowed to grow for 5 days. On day 5 the culture 
 medium was switched to CM (n = 3/CM time point); after 
incubation for further 9 days cell densities, viability, and 
proliferation were assessed (see below). Control cultures 
were kept in α-MEM supplemented with 1% antibiotics/
antimycotics (Sigma).
The different time periods of CM incubation for neurons 
and glial cells were mainly related to their maturation stage. 
For hippocampal neurons the maturation stage is 7 days 
while for cortical glial cells is 14 days [32,33].
Cell viability assessment
Cell viability was assessed by the MTS test. The MTS 
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2(4-sulfophenyl)-2H tetrazolium] (Promega, Madison, WI) 
test is an assay in which the substrate—MTS—is biore-
duced into a brown formazan product by NADPH or NADP 
produced by mitochondrial enzymes, which are active in 
living cells [34,35]. It is similar to MTT test, presenting the 
advantage of producing a 0 nal formazan product that is 
soluble in aqueous media. Cell culture coverslips (n = 3) 
were placed in culture medium containing MTS in a 5:1 
ratio and incubated in a humidi0 ed atmosphere at 37°C 
and 5% CO2. After 3 h of incubation, 100 µL of solution 
from each sample were transferred to 96-well plates and 
the optical density was determined at (450 nm) (n = 3/CM 
time point ± SD).
Cell proliferation
Cell proliferation was determined by a colorimetric assay 
based on 5-bromo-2′-deoxyuridine (BrdU) incorporation 
(Roche, Mannheim, Germany). Primary hippocampal and 
glial cell cultures incubated with CM, and respective con-
trols, were incubated with BrdU on days 6 and 13, respec-
tively. After 24 h of incubation, ELISA test was performed 
according to the company’s instruction in the end of which 
OD was determined at 450 nm with a reference 0 lter at 655 
nm. Results are shown as a ratio between CM-incubated cul-
tures and controls (n = 3/CM time point ± SD).
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in all CM-incubated cultures. This was observed namely for 
CM 24 h displaying a nearly 2-fold increase when directly 
compared to control cultures. Given that the glial cell cul-
ture system used in the present work contained all the glial 
there were also differences between the groups incubated 
with CM, namely between CM 24 h and CM 72 h (P < 0.05). 
Additionally it was also possible to observe that cell prolifer-
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FIG. 1. Glial cell incubation with human umbilical cord perivascular cells (HUCPVCs) conditioned media (CM). 
Experiments revealed that HUCPVCs CM increased glial cell viability (A) and proliferation (B) (all the values were statis-
tically signi0 cant different from the control, one way ANOVA, n = 3, mean ± SD, P < 0.05). For the immunocytochemistry 
glial cell cultures were stained for GFAP, Astrocytes; CD11b, Microglial cells; and O4, Oligodendrocytes. Total cell counts 
normalized to the content of total protein/well (C, D, E; cells/μg protein) revealed that these effects were mainly exerted 
on astrocytes (all CM time points statistically different from the control, one way ANOVA, n = 3, mean ± SD, P < 0.05) and 
oligodendrocytes (CM 24 h one way ANOVA, n = 3, mean ± SD, P < 0.05). Although nonsigni0 cative (one way ANOVA, n 
= 3 ± SD, P > 0.05) results obtained with microglial cells suggest that CM 24 h reduce the number of microglial cells. This 
fact alludes to the possible low in/ ammatory character of HUCPVCs.
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Our results showed that the CM, and thus the growth 
 factors secreted by HUCPVCs, did have a positive impact 
on different parameters of a primary glial cell culture sys-
tem. Moreover, this input of HUCPVCs CM on glial cells is 
mediated by proteic factors, as after heating up the different 
CM and therefore denaturing the proteic content the same 
effects were not observed (data not shown). With the present 
experiment, it was possible to observe that the secreted pro-
teins by HUCPVCs could increase the levels of cell viability 
and proliferation. In both cases CM 24 h has a more striking 
effect than the other CM. Although there is not a conclud-
ing reason for this observation, it is true that some nutrient 
depletion may occur while CM is being collected. However, 
as no major differences are found between CM 48 h and 72 h 
it would be also reasonable to suggest that the half-life of the 
secreted factors could also be playing a role on this subject. 
This is even more evident for the cell proliferation, where 
a near 2-fold decrease was observed when cultures were 
incubated with these 2 groups of CM. At the subpopulation 
level, it is possible to state that HUCPVCs release factors 
to the extracellular milieu that have a direct impact on the 
densities of astrocytes and oligodendrocytes. However, the 
response obtained by these 2 different cell subpopulations 
was different. Oligodendrocytes were more sensitive to the 
temporal pro0 le of CM collection. A closer observation of 
these results allows to establish a comparison to temporal 
pro0 les obtained for cell viability and proliferation, as all 
of them present the same trend. Once again this could be 
related to the half-life of the secreted factor(s) that is (are) 
playing a role on these observations. Nevertheless further 
studies need to be conducted in order to fully understand the 
reasons behind the observed phenomena. Finally, the results 
obtained for microglial cells suggest that the proteic factors 
released by the HUCPVCs did not induce the proliferation of 
these mediators of in/ ammatory response within the CNS 
and, therefore, alludes to the low in/ ammatory potential of 
these CM. This is would be in accordance to what has been 
previously described by Hirko et al. [24] and Ennis et al. [37] 
in mixed lymphocyte cultures.
cell types (astrocytes, oligodendrocytes, and microglial 
cells), we then proceeded to determine the effect of the CM 
incubation at the subpopulation level. As it can be observed 
in Figures 1 and 2, HUCPVCs’ CM had clear effects on the 
0 nal densities of both astrocytes and oligodendrocytes. This 
effect was present for all CM time points (P < 0.05) in astro-
cytic populations, while for oligodendrocytes there is, ap-
parently, a temporal pro0 le of growth factor expression that 
clearly stimulates oligodendrocyte cell densities at CM 24 h 
(P < 0.05), starting to decay from then on. Regarding micro-
glial cells, it was observed that cultures incubated with CM 
did not disclose higher values than those presented by con-
trol samples. In fact, the graph shown in Figure 1E indicates 
that cultures incubated with HUCPVCs CM had lower cell 
densities of microglial cells, namely those cultured with CM 
24 h.
Figures 3 and 4 show the results for the experiments per-
formed with primary hippocampal cultures. Cell viability 
assays revealed that in the absence of supplements the control 
cultures disclosed lower levels of cell viability, up to 3-fold 
smaller (P < 0.05) when compared to the CM-incubated 
cultures (Fig. 3A). Simultaneously, it was also possible to 
observe that CM 24 h (Fig. 3B) drastically increased cell pro-
liferation in this culture system (P < 0.05), while CM 48 h and 
72 h did not induce any changes in these parameters. MAP-2 
immunostaining showed that no differences were observed 
between the different CM groups for neuronal densities, but 
drastic differences were observed when compared to the con-
trol (P < 0.05), as the latter had almost undetected numbers 
of MAP-2-positive cells (Figs. 3C and 4).
Discussion
As one of the possible mechanisms by which non-neural 
adult stem cells act on neuronal cell populations is through 
the release of cytokines, growth factors, and neuroregula-
tory molecules, our work consisted on the incubation of hip-
pocampal neurons and glial cells with CM obtained from 





FIG. 2. Glial cell incubation with human um-
bilical cord perivascular cells (HUCPVCs) con-
ditioned media (CM). Immuno cytochemistry 
staining for GFAP (A, CM 24 h; B, Ct) and O4 
(C, CM 24 h; D, Ct) revealed that HUCPVCs 
released proteic factors that induce an in-
crease on astrocyte and oligodendrocyte cell 
densities. Abbreviations: GFAP, astrocytes; O4, 
Oligodendrocytes.
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cultures, as in the absence of neuronal supplements such as 
B27, the latter remain mainly in the undifferentiated state. 
Furthermore, it was also possible to observe that, in what 
concerns neuronal survival/differentiation, there are no dif-
ferences in the trophic capability of HUCPVCs CM differ-
ent time points of collection. These observations are a clear 
demonstration that HUCPVCs do in fact released neuro-
regulatory molecules that promote neural survival/differ-
entiation as no neural inducing factors were added to the 
CM. Moreover these factors seem to compensate the effects 
caused by the nutrient depletion during the CM collection, 
as otherwise cell viability and MAP-2 positive cell densi-
ties would have been decreased. Nevertheless the nature of 
these factors is at the moment unknown.
For the experiments with hippocampal neurons similar 
results were obtained for cell viability and proliferation. As 
it can be concluded from Figures 3 and 4, the CM collected 
from HUCPVCs for all time points increased the overall 
cell metabolic viability when compared to control cultures. 
Moreover it was also possible to observe that CM 24 h had 
notorious effects on the up-regulation of cell proliferation 
(P < 0.05). From these data one can conclude that the tested 
CM had different effects on the analyzed parameters, and 
thus CM 24 h is the most adequate to induce proliferation. 
Additionally immunocytochemistry for MAP-2 allowed to 
observe that the cultures incubated with the different CM 
had a higher number of MAP-2-positive cells when com-
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FIG. 3. Hippocampal neurons incubated with human umbilical cord perivascular cells (HUCPVCs) conditioned media 
(CM). Similarly to what was observed for glial cells, CM induced an increase of metabolic viability (all values statistically 
signi0 cant different from the control, one way ANOVA, n = 3, mean ± for SD, P < 0.05) was observed. MAP-2 cell counts 
normalized to the content of total protein/well revealed that there were drastic differences to the control (one way ANOVA, 
n = 3, mean ± SD, P < 0.05). Therefore it can be stated that HUCPVCs CM possess neuroregulatory molecules that increase 





FIG. 4. Immunocytochemistry staining for 
microtubule-associated protein 2 (MAP-2) on 
hippocampal neurons incubated with human 
umbilical cord perivascular cells (HUCPVCs) 
conditioned media (CM) (A) and respective 
control (B). It was observed that HUCPVCs CM 
induced a higher degree of neuronal survival/
differentiation when compared to controls.
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Conclusions
With the present work, it was possible to demonstrate 
that the CM of a population of mesenchymal progenitors 
present in the UC’s WJ, HUCPVCs, is able to increase cell 
viability and proliferation on primary cultures of glial cells. 
Additionally they also potentiate astrocyte and oligoden-
drocyte cell densities, without stimulating the proliferation 
of microglial cells, the immune system mediators of the 
CNS. Furthermore, it was also revealed that the secretome of 
HUCPVCs might also play a role in potentiating neural pro-
genitors proliferation, as well as neuronal survival/differ-
entiation. The experiments herein described, for both glial 
cells and hippocampal neurons, suggest that most of these 
effects are mediated by the release of growth/trophic factors 
by HUCPVCs in the extracellular milieu; future experiments 
will focus on the identi0 cation of these factors.
Acknowledgments
Portuguese Foundation for Science and Technology 
through funds from POCTI and/or FEDER programs 
(funding to ICVS, 3B’s Research Group and post doctoral 
fellowship to A.J. Salgado—SFRH/BPD/17595/2004); fund-
ing from Fundação Calouste de Gulbenkian. The authors 
would also like to acknowledge Prof. J.E. Davies from the 
Institute of Biomaterials and Biomedical Engineering at the 
University of Toronto, Canada, for kindly providing some of 
the HUCPVCs lots used in the present work. This work was 
performed following the terms of the cooperation agreement 
signed between the 3B’s Research Group of the University 
of Minho and the Hospital de São Marcos in Braga and 
approved by its ethical committee.
Author Disclosure Statement
No competing 0 nancial interests exist.
References
 1.  Morshead CM, BA Reynolds, CG Craig, MW McBurney, WA 
Staines, D Morassuti, Weiss S and Van der Kooy D. (1994). 
Neural stem cells in the adult mammalian forebrain: a rela-
tively quiescent subpopulation of subependymal cells. Neuron 
13:1071–1082.
 2.  Schneider A, C Krügler, T Steigleder, D Weber, C Pitzer, R Laage, 
J Aronowski, MH Maurer, N Gassier, W Mier, M Hasselblat, 
R Kollmar, S Schwab, C Sommer, A Bach, HG Kuhn and WR 
Schäbitz. (2005). The hematopoietic factor G-CSF is a neuronal 
ligand that counteracts programmed cell death and drives neu-
rogenesis. J Clin Invest 115:2083–2098.
 3.  Kang SK, DH Lee, YC Bae, HK Kim, SY Baik and JS Jung. (2003). 
Improvement of neurological de0 cits by intracerebral transplan-
tation of human adipose tissue-derived stromal cells after cere-
bral ischaemia in rats. Exp Neurol 183:355–366.
 4.  Fiore M, V Triaca, T Amendola, P Tirassa and P Aloe. (2002). 
Brain NGF and EGF administration improves passive avoid-
ance response and stimulates brain precursor cells in aged male 
mice. Physiol Behav 77:437–443.
 5.  Sharfman H, J Goodman, A Macleod, S Phani, C Antonelli and 
S Croll. (2005). Increased neurogenesis and the ectopic granule 
cells after intrahippocampal BDNF infusion in adult rats. Exp 
Neurol 192:348–356.
 6.  Scarisbrick LA, K Asakura and M Rodriguez. (2000). 
Neurotrophin-4/5 promotes proliferation of oligodendrocyte 
type 2 astrocytes (O-2A). Brain Res Dev Brain Res 123:87–90.
SALGADO ET AL.1074
34.  Cory AH, TC Owen, JA Barltrop and JG Cory. (1991). Use of an 
aqueous soluble tetrazolium/formazan assay for cell growth 
assays in culture. Cancer Commun 3:207–212.
35.  Salih V, K Franks, M James, GW Hastings and JC Knowles. (2000). 
Development of soluble glasses for biomedical use Part II: The 
biological response of human osteoblast cell lines to phosphate-
based soluble glasses. J Mater Sci Mater Med 11:615–620.
36.  Silva GA, FJ Costa, OP Coutinho, S Radin, P Ducheyne and RL 
Reis. (2003). In vitro degradation and cytocompatibility evalu-
ation of novel soy and sodium caseinate-based membrane bio-
materials. J Mater Sci Mater Med 14:1055–1066.
37.  Ennis J, C Götherström, K Le Blanc and JE Davies. (2008). In 
vitro immunologic properties of human umbilical cord perivas-
cular cells. Cytotherapy 10:174–181.
Address correspondence to:
Prof. Nuno Sousa
Life and Health Sciences Research Institute (ICVS)






Received for publication July 29, 2009
Accepted after revision August 25, 2009
Prepublished on Liebert Instant Online August 25, 2009
26.  Wislet-Gendebien S, F Bruyère, G Hans, P Leprince, G Moonen 
and B Rogister. (2004). Nestin-positive mesenchymal stem cells 
favour the astroglial lineage in neural progenitors and stem 
cells by releasing active BMP4. BMC Neurosci 5:33–44.
27.  Chen Q, Y Long, X Yuan, L Zou, J Sun, S Chen, JR Perez-Rolo 
and K Yang. (2005). Protective effects of bone marrow stromal 
cell transplantation in injured rodent brain: synthesis of neu-
rotrophic factors. J Neurosci Res 80:611–619.
28.  Munoz RM, BR Stoutenger, AP Robinson, JL Spees and DJ 
Prockop. (2005). Human stem/progenitor cells from bone mar-
row promote neurogenesis of endogenous neural stem cells in 
the hippocampus of mice. PNAS 102:18171–18176.
29.  Crigler L, RC Robey, A Asawachaicharn, D Gaupp and DG 
Phinney. (2006). Human mesenchymal stem cell subpopula-
tions express a variety of neuro-regulatory molecules and 
promote neuronal survival and neuritogenesis. Exp Neurol 
198:54–64.
30.  Sarugaser R, D Lickorish, D Baksh, MM Hosseini and JE Davies. 
(2005). Human umbilical cord perivascular cells (HUCPV) cells: 
a source of mesenchymal progenitors. Stem Cells 23:220–229.
31.  Baksh D, R Yao and RS Tuan. (2007). Comparison of proliferative 
and multilineage differentiation potential of human mesen-
chymal stem cells derived from umbilical cord and bone mar-
row. Stem Cells 25:1384–1392.
32.  Lu J, Y Wu, N Sousa and OF Almeida. (2005). SMAD pathway 
mediation of BDNF and TGF beta 2 regulation of prolifer-
ation and differentiation of hippocampal granule neurons. 
Development 132:3231–3242.
33.  Giulian D and T Baker. (1986). Characterization of ame-
boid microglia isolated from developing mammalian brain. J 
Neurosci 6:2163–2178.
